{"name":"Fresh Tracks Therapeutics, Inc.","slug":"fresh-tracks-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQX29PTXdOWFJNS1duZWVZbE5nNndRUlBDZjJPVkJoZmdDTTZqdVR5ZVQ1NDdpU29kaERrc28yMEV2VEVhWDNqbEZxRHFEVFZHbXV0S0dRLVdVclAxQUQ2eFhtYTFmQ09JakZzZVdQeTBpaHRTa3dvSHMwYU5ROEt0VGJWalR1ZWJHN1J6b3IxNUc0UWdpWDVVWHdkQV9LMEg1M3MxTnZnSlFBNTIyN1Jvcg?oc=5","date":"2026-04-08","type":"pipeline","source":"Fierce Pharma","summary":"Invivyd launches ‘Antibodies for Any Body’ campaign with Olympic skier Lindsey Vonn - Fierce Pharma","headline":"Invivyd launches ‘Antibodies for Any Body’ campaign with Olympic skier Lindsey Vonn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPcUlUanduV1RhVTVySGxucnhCb0dpMVZTT0xnZnF0N3dxZVlvUGZxTWFRV240WHlYR3Bhb0hFTHpEU0pOSHBkZ3FJLWhfaktTMDItWTE3Z2EzcTlJcVhYN1hZNUNNRmxyZjhJb2poYlcwRFc1VlhZb1U1bnpCT0FQejN2VmpyNGM3Z3dwSEVtN0JDelE?oc=5","date":"2026-04-06","type":"pipeline","source":"San Diego Business Journal","summary":"Spin-off Imminent At AnaptysBio - San Diego Business Journal","headline":"Spin-off Imminent At AnaptysBio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwJBVV95cUxQczFaMW1rekJaNmo3bVNnMEJQUmJkSWxPa0tQYmt0T2I3TW5CY1F3VmQ0eWpKcjZDOWVpMnNFQjFkd01ZSkQwRTI4TDRjTF9KMS1VRFNoODBObDE3elJaVTVZN1lvRmMtVl9COU1LX3dZRFlCSkdfcDYxVzNza1dWSU1ZbUoyUlRyZUt6TVZLVTRHYjhhYnozNG91TzhpTUxoVVhUNjlER0huVGFSV3ctb2gtMWE1NU4wSEhBWkJLbkk1amtmbFhVS09UcVF6QXNQR1dFQmczRDhZZENrUVJRVlVPVDNLaDVqZkJ3R2Vvbi1EYjk2R1dyVU1VQkctaTBKM0EycmZPNXVRQnJ3OWpzVFRrUW0wVWxFdWdqLUhhUUtyV0lsSUdHVmh4MS1XMUJTLS02SzJUWl8xdmYwSDE4?oc=5","date":"2026-04-01","type":"regulatory","source":"GlobeNewswire","summary":"Systemic Lupus Erythematosus Clinical Trial Pipeline - GlobeNewswire","headline":"Systemic Lupus Erythematosus Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxPVnZGYTBfR3o4czAtRFJXU1dwX190aXBvd3dCVUhxUnZXekRSeDR1TmN4ZkpHZWhVSlVBcWNVNXlXYmVQamUzWm9UR0hfY0pkaDNzV0NPdGV1aXFDREEzTGZTOUk0aEppbk9GUGs5b3R6MGdOOHR4djRLTkh2OW1Ub2t0dGh6SUV5VEctOFpOTzRHb05OSmRSVUQzRjhOOEZpZ3hfQ1hONzk0dm9xeEZqeTczSFBoWjllakRONGEzRzI1RDAxMlF6NmM3b0JYajJBWG1oU3dPczFZTkt6a3ZFeU5ER1pkZ0t6S21KVnUzVjhfRV9qRGJNb01HNkVUSVNIV0pmdEU4YU9fcGJBWmU0?oc=5","date":"2026-02-16","type":"pipeline","source":"prnewswire.com","summary":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight - prnewswire.com","headline":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQQWF4bjBGZURZNXMyM2dVMGl2eURNclVlcUFjbFpxXy1TLV9mb0Myc1lhTFlUVG9lSm1YaEd5bkFSN3dReGtLRkFGaHdWQ3EtQWNYTzJOTnNOSFlSTVE2UVF4LXNab0s2V1ZtVzl4WHBpN2ctY0lQVGhBQUFCb1JtM1IySjFmaDlLQ2ZCYVhfQms5RTIzVXo2RXA4R2plVF9mYlBF?oc=5","date":"2025-11-04","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in October 2025 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in October 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPUF9xZGcxVHFJSXU5WEpzWXJUOTNkUklqRENQUEJCdGZSWVJUME5SQ1JVemZESGZHWnJqdWFqNXQ2Tk4zS1NHdFpucDBHRFR4Wkk5a3k4OWZfNUotMlZsN1BzTGpHNlN6SVduZVNNeE5YYUhzOWIzcDFDUVBWam5aWDg4V0ZDVjJqaFFhSnpQZEZsV1VUU0xqX2E5S3dYa1F5b2V3b2VRRlZNaVRaVXdhMmZTU3ZmWTl1aUZwY2RR?oc=5","date":"2025-05-08","type":"earnings","source":"Intellia Therapeutics - investor relations","summary":"Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress - Intellia Therapeutics - investor relations","headline":"Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress - Intellia T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE4zYkYwdkUyNkpqMXl4VmozRE9jZi01NFpwVF9xYlJ3dmxMOTdnN3ZENGVKeHZoWlB1THNFNnBOZ2ZWNDYteWxyQW5wTVIyeEVUZ3hF?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"FRTX Stock Price, News & Analysis - Stock Titan","headline":"FRTX Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPX2EyakxveElSbFoxM002Nmo0d0JUMURVRjNtUUtFa0M4eEtla0tkWDRvdEV1M0FSTzRhY2hUR3hSaTBHYXVOQnQyOWdxT3pNYXQ4V1ZVZVUtQmlXUURFX2E5NXhqMDVBUE1xa2tVQzFOR1dCYlRTaEZTV2lraENtZ29SblluMkpydktQN2tKUUdZX2JrU2J0MVpTQi1LVlpzWHMzemhPMGpQMHhuWnc?oc=5","date":"2023-11-13","type":"pipeline","source":"BizWest","summary":"Fresh Tracks expects to distribute $5M to $7M to shareholders after dissolution - BizWest","headline":"Fresh Tracks expects to distribute $5M to $7M to shareholders after dissolution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNNnNELWRHeTJYRHhfWXdOdU1fQXJYY2dYaVFkMG5CdWpjUXhRbjhSSmE5ZXppbk1ZTTBSTmZPS3lkNjlTaW1CVS16RkJRVTNkb1BUaEtMMU5nZ0hsamRLOEgxaEZLemxLdmlLc05lVlBoWDluUUxubXdCajFsUFpzUmJOYUl3dG1hbmcyRlgtSzdpUFczR0xBdHJn?oc=5","date":"2023-09-20","type":"pipeline","source":"BioSpace","summary":"Fresh Tracks, Histogen to Shutter Businesses in Absence of Viable Options - BioSpace","headline":"Fresh Tracks, Histogen to Shutter Businesses in Absence of Viable Options","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQU29LVGFZMmZ3aUI1cTBTMWVPcEg1RW9uOWQwQW5EUFBzTWlXVTM1UEYyM0lTVlRVeFdpWkQ1bVNBYk9sdWFKOG85aU1vek00SE1HRGdVZXhlU29UOFd1QnlhMFhmdHYwTlRGbzJFS1RQS3UyUU0yVXIxR2c0RHBQb1U5Z2ttVXI0eFYzMmJzRHdRUC1HbHdvRmREYw?oc=5","date":"2023-09-19","type":"deal","source":"Fierce Biotech","summary":"Fresh Tracks to dissolve after hunt for buyer comes up empty - Fierce Biotech","headline":"Fresh Tracks to dissolve after hunt for buyer comes up empty","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQNEJNenFqQmp3MUxKWWZybGlrODczOW8zS3E1ZjRGUzB6YlZpWENLNjd2SXhJMjlKRUF6YjhaMUlMNGQxSDJKRFJ2UDBKekdaR0dZUk9nbElnQUZPVm5hV3BLYmlFZTRiWXRXbURwQ1plRTIyY0Qta2tJZk85Z0ZvTkI5aUxSV05WQnROdHk2NUxvZWdSeFdFU0tYQnJnNG8tbzFOVVhyclhzVVE0cWk4?oc=5","date":"2023-08-14","type":"deal","source":"Fierce Biotech","summary":"Cash-strapped Fresh Tracks pauses R&D run as search for a buyer continues - Fierce Biotech","headline":"Cash-strapped Fresh Tracks pauses R&D run as search for a buyer continues","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}